Results 121 to 130 of about 36,076 (253)

Different Immune Cells Modified With Chimeric Antigen Receptors Are Being Applied to Ovarian Cancer: Which Is the Most Effective?

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Ovarian Cancer (OC), the deadliest gynecological malignancy, poses a major therapeutic challenge in advanced stages owing to its high recurrence rate and metastatic potential. In this regard, it is noteworthy that immunotherapy has recently gained significant attention in OC treatment, a phenomenon attributable to notable advances in over‐the ...
Liying Wang, Yisen Cao, Yuan Ren, Yuhang Zhang, Liang Wang   +4 more
wiley   +1 more source

Secondary hemophagocytic lymphohistiocytosis in children with brucellosis: report of three cases

Journal of Infection in Developing Countries, 2015
Brucellosis is a systemic zoonotic infectious disease that may cause fever, fatigue, sweating, arthritis, hepatosplenomegaly, cytopenia, and lymphadenopathy. It continues to be an important health problem worldwide.
Yöntem Yaman, Salih Gözmen, Ahmet Kağan Özkaya, Yeşim Oymak, Hurşit Apa, Canan Vergin, İlker Devrim   +6 more
doaj   +1 more source

Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore

Critical Care, 2020
Background Hemophagocytic lymphohistiocytosis (HLH) is a rare though often fatal hyperinflammatory syndrome mimicking sepsis in the critically ill. Diagnosis relies on the HLH-2004 criteria and HScore, both of which have been developed in pediatric or ...
Cornelia Knaak, Peter Nyvlt, Friederike S Schuster, C. Spies, Patrick Heeren, T. Schenk, F. Balzer, P. La Rosée, G. Janka, F. Brunkhorst, D. Keh, G. Lachmann   +11 more
semanticscholar   +1 more source

Severe Adult HLH/MAS With SPTCL‐Like Panniculitis: A Phenotype‐Guided, Resource‐Adapted Therapeutic Strategy Without Cytotoxic Therapy

Clinical Case Reports, Volume 14, Issue 5, May 2026.
Graphical abstract illustrating the phenotype‐guided therapeutic approach in severe adult HLH/MAS with SPTCL‐like panniculitis, demonstrating clinical and biochemical response following sequential treatment with therapeutic plasma exchange, intravenous immunoglobulin, and cyclosporine.
Hatem Mousa Taha, Omar Marouf, Khaled Hatem Taha   +2 more
wiley   +1 more source

Screening assays for primary haemophagocytic lymphohistiocytosis in children presenting with suspected macrophage activation syndrome [PDF]

, 2014
BACKGROUND: Primary haemophagocytic lymphohistiocytosis (HLH) screening assays are increasingly being performed in patients presenting with macrophage activation syndrome (MAS).
Anoop, P, Brogan, PA, Cruikshank, M, Eleftheriou, D, Gilmour, K, Nikolajeva, O, Rao, A, Rao, K   +7 more
core  

X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective [PDF]

, 2018
X-linked lymphoproliferative disease (XLP) was first described in the 1970s as a fatal lymphoproliferative syndrome associated with infection with Epstein–Barr virus (EBV).
Baldanzi, Bar, Bergsten, Bloch-Queyrat, Booth, Booth, Booth, Bottino, Candotti, Cannon, Cannons, Cannons, Cannons, Cannons, Chan, Chan, Chen, Chu, Chung, Coffey, Cohen, Crotty, Crotty, Czar, Das, Dong, Dong, Dupré, Dutz, Freeman, Gadue, Georgiadis, Ghosh, Gilmour, Grierson, Griewank, Harada, Harrington, Henter, Hislop, Holt, Hron, Jordan, Kageyama, Kanegane, Kim, Kohn, Lankester, Latour, Latour, Li, Loeffel, Ma, Ma, Marsh, Marsh, McCausland, Mejstríková, Menard, Milone, Morra, Nakajima, Nichols, Nichols, Nichols, Ochs, Pachlopnik Schmid, Palendira, Palendira, Parolini, Pasquier, Pawson, Porteus, Poy, Provisor, Purtilo, Purtilo, Qasim, Qi, Rigaud, Rivat, Rougemont, Ruffo, Sayos, Schwartzberg, Seemayer, Sepulveda, Shlapatska, Snow, Sullivan, Sumegi, Sumegi, Talaat, Tangye, Tangye, Tangye, Thorley-Lawson, Veillette, Victora, Worth, Wu, Wu, Wu, Yin, Zhang, Zhao   +105 more
core   +1 more source

Phagocytic Mesothelial Cells in Pericardial Effusion Following Allogeneic Peripheral Blood Stem Cell Transplantation for Chronic Active Epstein–Barr Virus Infection: A Distinctive Cytomorphological and Immunocytochemical Case Study

Diagnostic Cytopathology, Volume 54, Issue 5, Page E136-E139, May 2026.
ABSTRACT Phagocytic activity of mesothelial cells is a rare phenomenon requiring careful differentiation from histiocytic hemophagocytosis to ensure appropriate patient management, as these phenomena could exhibit distinct clinical implications. In this study, we report a case of phagocytic mesothelial cells found in pericardial effusion that developed
Hidetoshi Satomi, Ayumi Ryu, Sei Murayama, Hiroya Kojima, Satoshi Tanada, Keiichiro Honma   +5 more
wiley   +1 more source

Disseminated tuberculosis and hemophagocytic syndrome although TB prophylaxis in patients with inflammatory bowel disease treated with Infliximab

IDCases, 2019
Purpose: We present de case of a 27-year-old woman admitted to ICU after scheduled splenectomy to study her short course of fever, leukopenia and splenic space-occupying lesions and splenomegaly.
Modesto Martínez-Pillado, Marina Varela-Durán, Ismael Said-Criado, Pilar Díaz-Parada, María Rodríguez-Losada, María Mendoza-Pintos   +5 more
doaj   +1 more source

Loomulike tappurrakkude aktiivsuse tsütomeetriline määramine [PDF]

, 2008
Loomulikud tappurrakud (ingl natural killers, NK) on loomulikku immuunsust tagavad lümfotsüüdid, mis on võimeli­sed hävitama teisi rakke ilma eelneva immunoloogilisekogemuseta.
Aints, Alar, Everaus, Hele, Štšerbakova, Anna   +2 more
core   +2 more sources

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source